Rifabutin
Tier C — Watch / tradeRifabutin
Targets：RNAP
Brand：Mycobutin, Ansatipin, Ansatipine
Indications (approved)：Multidrug-resistant tuberculosis, Mycobacterium avium-intracellulare complex disease
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| RIFAB-001 | 2353416-91-6 | - |
| RIFAB-002 | 1268698-55-0 | SMPJCQGFZSDIHE-XZEREJJPSA-N |
| RIFAB-003 | 62041-01-4 | - |
| RIFAB-004 | 72544-16-2 | 1-isobutylpiperidin-4-one |
Frequently asked questions
What are the approved indications of Rifabutin?
Approved indications include: Multidrug-resistant tuberculosis, Mycobacterium avium-intracellulare complex disease.
When does the Rifabutin patent expire?
No public expiry year is available for Rifabutin yet; this page updates once verified.
How many synthesis routes are recorded for Rifabutin?
1 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Rifabutin intermediates?
All intermediates in Rifabutin routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Rifabutin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29